A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

NCT04072458 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Mantle Cell Lymphoma
Peripheral T-cell Lymphoma (PTCL)
Cutaneous T-cell Lymphoma (CTCL)
Chronic Lymphocytic Leukemia (CLL)
Small Lymphocytic Lymphoma (SLL)
Follicular Lymphoma
Marginal Zone Lymphoma
Hodgkin Lymphoma
Waldenstrom Macroglobulinemia
DLBCL

Interventions

DRUG: L-Bcl-2 antisense oligonucleotide

Sponsor

Bio-Path Holdings, Inc.